RxDoctor Payments Data

Steven Garner, MD

Family Medicine · Derby, KSNPI 1710996640

Payments from drug & device makers

$312in general payments, 2019–2025

Across 22 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$87
  • Boehringer Ingelheim$48
  • Novo Nordisk$44
  • GSK$25
  • Astellas Pharma US Inc$17
  • Supernus Pharmaceuticals, Inc.$16
  • plus $74 from 6 others

What the payments were for

  • Food & beverage$29896%
  • Education$144%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$312 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$202,030
Medicare patients
540
Services billed
9,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban162$101,615
OzempicSemaglutide58$71,069
JardianceEmpagliflozin60$52,004
JanuviaSitagliptin Phosphate54$36,004
XareltoRivaroxaban45$31,487
Tresiba Flextouch U-200Insulin Degludec19$25,112
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$19,812
LinzessLinaclotide23$16,779
Breo ElliptaFluticasone/Vilanterol25$12,578
Synjardy XrEmpagliflozin/Metformin Hcl13$12,550
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$10,357
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog23$10,209
CreonLipase/Protease/Amylase17$9,425
InvokanaCanagliflozin17$9,329
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$7,833

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$44$71,06958 claims
Boehringer IngelheimJardiance, Synjardy Xr$48$64,55473 claims
Johnson & JohnsonXarelto, Invokana$12$40,81762 claims
MerckJanuvia$11$36,00454 claims
GSKTrelegy Ellipta, Breo Ellipta$25$32,39054 claims
AstraZenecaBreztri Aerosphere, Brilinta, Symbicort$12$19,09541 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Derby

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →